Credence MedSystems Receives a Strategic Investment From One of the World’s Leading Pharmaceutical Companies

MENLO PARK, Calif.--(BUSINESS WIRE)--Credence MedSystems announced today that Novartis has made a strategic investment in the Company. The investment will advance ongoing development and scaling of Credence’s innovative drug delivery systems, with an initial focus on the Credence Companion® Safety Syringe System. With the investment in Credence, Novartis seeks to support its patients, caregivers, and healthcare professionals by enhancing the safety and user experience during administration of N

Full Story →